Yahoo Finance

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

SAN JOSE, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral ...
Pharmabiz

Maruho introduces Mitchga SC injection 30mg vials, an antibody treatment for pruritus associated with atopic dermatitis (paediatric) and prurigo nodularis in Japan

Maruho Co., Ltd. announces that it has launched Mitchga subcutaneous (SC) injection 30mg vials (Japanese Accepted Name (JAN): Nemolizumab (genetical recombination), in Japan for the treatment of the ...
Monthly Prescribing Reference

SC Injectable Vyvgart Hytrulo Gets FDA Nod for Generalized Myasthenia Gravis

Credit: Argenx. Vyvgart Hytrulo is a combination of efgartigimod alfa, a neonatal Fc receptor blocker, and hyaluronidase, an endoglycosidase. The Food and Drug Administration (FDA) has approved ...
Yahoo Finance

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as quickly as possible “We are pleased to introduce the first subcutaneous PD-L1 cancer ...
PharmiWeb

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Basel, 16 January 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq® SC (atezolizumab), the European Union (EU)’s ...
조선일보

Celltrion Pharm launches biosimilar Avtozma for autoimmune diseases in South Korea

Celltrion Pharm announced on the 2nd that it will begin domestic sales of 'Avtozma' (a biosimilar of ACTEMRA, ingredient name tocilizumab), a treatment for autoimmune diseases. ACTEMRA, developed by ...